BRISBANE, Australia--(BUSINESS WIRE)--Microba Life Sciences Limited (ASX: MAP) (“Microba” or the “Company”) is excited to announce it has identified three therapeutic leads for the Company’s ...

Microba Life Sciences Limited (ASX: MAP) (“Microba”) a precision microbiome company, today announces two significant developments: the release of new clinical utility results for its MetaPanel™ ...

BRISBANE, Australia--(BUSINESS WIRE)--$MAP--Microba Life Sciences Limited (ASX: MAP) (“Microba” or the “Company”) is an Australian-based commercial stage ...

Even if it's not a huge purchase, we think it was good to see that Alexander Waislitz, a Microba Life Sciences Limited (ASX:MAP) insider, recently shelled out AU$126k to buy stock, at AU$0.32 per ...

A next generation human gut microbiome testing product range called MetaXplore™ has been launched in Australia to healthcare professionals. The MetaXplore™ range provides diagnostic gastrointestinal ...

The analysts covering Microba Life Sciences Limited (ASX:MAP) delivered a dose of negativity to shareholders today, by making a substantial revision to their statutory forecasts for this year. Revenue ...

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...

Australian gut health startup Microba has been using the Google Cloud Platform (GCP) to gain a deeper understanding of customers' gut microbiome. According to Microba, the gut microbiome plays a ...

Appointment of Professor Trent Munro as Senior Vice President of Therapeutics. Professor Munro has over 25 years’ research and development experience, including with multinational biopharmaceutical ...

Leaders in precision gut microbiome science Microba Life Sciences has united with Illumina, Inc. (NASDAQ: ILMN), the global leader in DNA sequencing and array-based technologies, to advance ...

Passive investing in an index fund is a good way to ensure your own returns roughly match the overall market. When you buy individual stocks, you can make higher profits, but you also face the risk of ...

Two independent clinical studies have demonstrated that Microba’s MetaPanel™ test identifies gastrointestinal pathogens in >35% of Inflammatory Bowel Disease (IBD) patients experiencing flare, with ...